Odyssey Health (ODYY) Profit After Tax Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -6.51% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.96% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | -2.39% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 62.16% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 3.79% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 30.83% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 60.12% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 3.38% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 6.53% |
| 10 | Odyssey Health | - | - | - | -29.15% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | -29.15% |
| Oct 31, 2025 | 39.19% |
| Jul 31, 2025 | 49.92% |
| Apr 30, 2025 | 56.69% |
| Jan 31, 2025 | 49.34% |
| Oct 31, 2024 | 14.78% |
| Jul 31, 2024 | -63.77% |
| Apr 30, 2024 | 59.20% |
| Jan 31, 2024 | 158.50% |
| Oct 31, 2023 | 8.89% |
| Jul 31, 2023 | 15.14% |
| Apr 30, 2023 | -8.72% |
| Jan 31, 2023 | -40.64% |
| Oct 31, 2022 | -14.91% |
| Jul 31, 2022 | 55.78% |
| Apr 30, 2022 | -266.86% |
| Jan 31, 2022 | -151.45% |
| Oct 31, 2021 | -187.20% |
| Jul 31, 2021 | -208.39% |
| Apr 30, 2021 | -452.42% |
| Jan 31, 2021 | -52.06% |
| Oct 31, 2020 | -123.88% |
| Jul 31, 2020 | -173.95% |
| Apr 30, 2020 | -132.01% |
| Jan 31, 2020 | -168.13% |
| Oct 31, 2019 | -301.61% |
| Jul 31, 2019 | -757.07% |
| Apr 30, 2019 | -97.21% |
| Jan 31, 2019 | -87.69% |
| Oct 31, 2018 | -40.62% |
| Jul 31, 2018 | -60.19% |
| Apr 30, 2018 | -20.07% |
| Jan 31, 2018 | -69.62% |
| Oct 31, 2017 | -13.40% |